Prestrelski Steven
Chief Scientific Officer
1 company
Prestrelski Steven is a Chief Scientific Officer at XERS. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $6.0M at current prices.
Prestrelski Steven's largest disclosed position is in XERS as Chief Scientific Officer, worth about $6.0M. The recent filings there lean toward selling, a net 11,228 shares.
Holdings by Company
XERSJan 31, 2023
Current Shares719.8K
Value$6.04M
Net Activity-11,228
Bought: 0Sold: 11.2K
Transaction History
Showing 1 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | XERS Xeris Biopharma Holdings, Inc. | Chief Scientific Officer | Sale+OE | 11,228 | $2.42 | $27,158.29 | -1.9% | -8.8% | -47.5% |